Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NET Power To Contact Him Directly To Discuss Their Options

Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.

RIG secures $100M backlog boost as EQNR extends Transocean Spitsbergen rig deal into 2026.

PLUG narrows losses and cuts its cash burn nearly in half as Project Quantum Leap aims to reshape its financial trajectory.

Markel Group is set to grow on rate increases, strategic buyouts, new business volume, solid capital position and prudent capital deployment.

Besides Wall Street's top -and-bottom-line estimates for Oracle (ORCL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended May 2025.

Evaluate the expected performance of Oxford Industries (OXM) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Nvidia (NASDAQ: NVDA) insiders are accelerating their selling spree, with one of the company's largest shareholders cashing out a substantial stake.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DoubleVerify To Contact Him Directly To Discuss Their Options

Tesla's stock is driven by sentiment, which has soured greatly. Plus, Musk has now alienated Republicans and Democrats alike.

The market offers growth opportunities driven by rising demand for gluten-free and health-conscious options, and the popularity of Asian cuisine. Convenience and innovation in products, like organic and pre-cooked noodles, further enhance market potential amidst growing competition from traditional wheat-based options. The market offers growth opportunities driven by rising demand for gluten-free and health-conscious options, and the popularity of Asian cuisine. Convenience and innovation in products, like organic and pre-cooked noodles, further enhance market potential amidst growing competition from traditional wheat-based options.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma Ltd. (NASDAQ: URGN) between July 27, 2023 and May 15, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2025.

CEG rides nuclear momentum with strong demand, new reactor plans, and a 26.4% stock surge over three months.

STNE's broad Q1 repricing initiative raises gross profit by 19% and EPS by 36%, outpacing guidance despite rate headwinds.

TEM's rapid growth and cost discipline are paving the way for a positive adjusted EBITDA in 2025.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BigBear.ai To Contact Him Directly To Discuss Their Options

Environmental, social, and governmental (ESG) investing is proving to be a prevailing trend. Amid a growing bond market, consider a specific ETF from Vanguard.

The dog days of summer don't apply to traders. Seeking profits is an all-season affair.

Disney (DIS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Palo Alto (PANW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.